ACCESS RESTRICTED TO VERIFIED HEALTH PROFESSIONALS 

For healthcare professionals

Intended purpose & regulatory information

Clinical guidance for healthcare professionals using the Nurochek-Pro System.

Prescription use only Aid to diagnosis

Intended purpose

The labelled purpose of the system.

Intended use

The Nurochek-Pro System is intended for prescription use in healthcare facilities for patients aged between 12 and 44 years old, for the aid in diagnosis of mild traumatic brain injury (mTBI) in conjunction with a standard neurological assessment. Rx only

The Nurochek-Pro System is indicated for the generation of visual evoked potentials (VEPs) and to acquire, transmit, display, and store electroencephalograms (EEGs) during the generation of VEPs. Additionally, the system is indicated to analyse captured EEG signals to provide an aid in the diagnosis of mild traumatic brain injury (mTBI) in patients aged between 12 and 44 years old who have sustained a potential head injury in the past 120 hours (5 days).

Clinical use context

How the system is used.

Qualified supervision

To be used by, or under the supervision of, qualified healthcare professionals.

Aid to diagnosis

As an aid to diagnosis, in conjunction with a standard neurological assessment.

Objective data

To provide objective, quantitative brain-function data to support clinical judgment, within the intended purpose.

Important safety information

This device should only be used by trained operators familiar with its intended use. Observe the following before operating the Nurochek-Pro System.

Medical supervision

Use under direct medical supervision or by a medical professional. Wear medical examination gloves when cleaning, fitting and handling the headset.

Photosensitive epilepsy

The headset produces bright flashing lights that may trigger a seizure. Use clinical judgement before exposing a patient to the visual stimulus.

Power source

Power only via the supplied USB-A connection with a medical-grade or IEC 60601-compliant computer, an approved USB isolator, or a laptop not connected to mains power.

No repair or modification

Do not repair, disassemble, service or modify the headset or its accessories. Report any faults to the manufacturer for assessment.

Defibrillator use

The headset and accessories are not defibrillator-proof. Remove the headset and all accessories from the patient before defibrillation.

Reprocess between uses

Follow the reprocessing instructions before use and between every patient to mitigate potential biohazards.

Contraindications

Do not use the device where any of the following apply.

  • History of epilepsy and/or seizures
  • Existing structural brain injury and/or condition
  • Blindness
  • Open head wounds or breached skin in contacting areas

Potential adverse events

Discontinue use on the patient and seek medical advice if these occur.

  • Discomfort from prolonged headset useDiscontinue · seek advice
  • Eyestrain from the visual stimulusDiscontinue · seek advice
  • Flicker vertigo from the visual stimulusDiscontinue · seek advice
  • Seizure in photosensitive epilepsyFirst aid · call ambulance

Regulatory status by jurisdiction

Where the device stands.

Regulatory status is stated as fact. Status in one jurisdiction does not imply approval, endorsement or availability in another.

United States

FDA cleared

The Nurochek™-Pro System has received FDA 510(k) clearance as a Class II medical device for the aid in diagnosis of mild traumatic brain injury (mTBI).

510(k) number
K243426
Regulation
21 CFR 882.1450
Product codes
PIW · OMC
Cleared
25 Feb 2025

New Zealand

WAND notified

Notified on the WAND (Web Assisted Notification of Devices) database and available in New Zealand.

WAND is a notification system; it is not a pre-market approval and does not constitute a Medsafe assessment or endorsement of the device.

Australia

In progress

Not yet included in the ARTG; not available for supply in Australia.

ARTG inclusion in progress.